EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management

Marcello Verini, Nicola Pietro Consilvio, Sabrina Di Pillo, Anna Cingolani, Cynzia Spagnuolo, Daniele Rapino, Alessandra Scaparrotta, Francesco Chiarelli

Journal of Allergy · 2010

DOI: 10.1155/2010/691425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy, 2010. Verfasst von Marcello Verini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Allergological and Pneumological Service, Department of Pediatric, University "G. D'Annunzio", 66100 Chieti, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to verify FeNO usefulness, as a marker of bronchial inflammation, in the assessment of therapeutic management of childhood asthma. We performed a prospective 1-year randomized clinical trial evaluating two groups of 32 children with allergic asthma: “GINA group”, in which therapy was assessed only by GINA guidelines and “FeNO group”, who followed a therapeutic program assessed also on FeNO measurements. Asthma Severity score (ASs), Asthma Exacerbation Frequency (AEf), and Asthma Therapy score (ATs) were evaluated at the start of the study (T1), 6 months (T2), and 1 year after (T3). ASs and AEf significantly decreased only in the FeNO group at times T2 and T3 ( p[T1-T2] = 0.0001, and p[T1-T3] = 0.01; p[T1-T2] = 0.0001; and p[T1-T3] < 0.0001, resp.). After six months of follow-up, we found a significant increase of patients under inhaled corticosteroid and/or antileukotrienes in the GINA group compared to the FeNO group (). Our data show that FeNO measurements, might be a very useful additional parameter for management of asthma, which is able to avoid unnecessary inhaled corticosteroid and antileukotrienes therapies, however, mantaining a treatment sufficient to obtain a meaningful improvement of asthma.

Autor:innen und Institutionen

  • Allergological and Pneumological Service, Department of Pediatric, University "G. D'Annunzio", 66100 Chieti, Italy.

Zitieren

APA

Verini, M., Consilvio, N. P., Di Pillo, S., Cingolani, A., Spagnuolo, C., Rapino, D., Scaparrotta, A., & Chiarelli, F. (2010). FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management. Journal of Allergy. https://doi.org/10.1155/2010/691425

Vancouver

Verini M, Consilvio NP, Di Pillo S, Cingolani A, Spagnuolo C, Rapino D, et al. FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management. Journal of Allergy. 2010. doi:10.1155/2010/691425

BibTeX
@article{Verini2010,
  author = {Verini, Marcello and Consilvio, Nicola Pietro and Di Pillo, Sabrina and Cingolani, Anna and Spagnuolo, Cynzia and Rapino, Daniele and Scaparrotta, Alessandra and Chiarelli, Francesco},
  title = {FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management},
  journal = {Journal of Allergy},
  year = {2010},
  doi = {10.1155/2010/691425}
}
Kostenlos starten →